BioCryst Pharmaceuticals On Our Radar: Can ORLADEYO™ Cause Another Revival?
BCRX

Breakout Stocks   Corona Virus Stocks  This week BioCryst Pharmaceuticals, Inc. ($BCRX) announced FDA approval of ORLADEYO™ (berotralstat), the first oral and once-daily therapy to prevent seizures in hereditary angioedema patients. To top it all off, the company subsequently announced a $325 million financing together with Royalty Pharma and Athyrium Capital Management. ORLADEYO™ ORLADEYO™ offers patients with…

The Best 50 OTCQX Companies of 2020: Is H20 Innovation, Inc. The Next Water Giant?
HEOFF

Gold Stocks Are Hot – Which Are In Play !  The Canadian H2O Innovation, Inc. (OTCQX: HEOFF) (CVE: HEO) is a leader in specific water and wastewater treatment solutions using membrane technologies. Thanks to its innovative, integrated water treatment systems its customer base includes municipal, industrial and commercial users. An essential segment in which the…